Abstract
Variability exists regarding the timing and duration of anticoagulation after surgical ablation for atrial fibrillation and bioprosthetic mitral valve replacement (MVR). We report a case in which a patient developed a massive left atrial (LA) thrombus after MVR and left-sided radiofrequency ablation (LRFA). Despite acutely elevated gradients across the bioprosthetic valve, the patient remained asymptomatic and hemodynamically stable; thus, a multidisciplinary, patient-centered discussion was had and the patient was treated successfully with oral anticoagulation.
Original language | English |
---|---|
Pages (from-to) | 389-392 |
Number of pages | 4 |
Journal | Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery |
Volume | 15 |
Issue number | 4 |
DOIs | |
State | Published - Jul 1 2020 |
Keywords
- anticoagulation
- thrombolytics
- thrombus